Submit Deal

SWIXX BIOPHARMA

HQ - Baar

Summary

Swixx BioPharma is a Switzerland-based provider of pharmaceutical commercialization services, active across Central & Eastern Europe, Eurasia, Greece, the Middle East, and Latin America.

Deals Overview

Total Deals3

Valued Deals1

Total Value£ 34 M

Avg. Deal Size£ 34 M

Market Context

Senior Management

Jean-Michel Lespinasse
CEO
Petr Pipal
CFO
Michael Seeley
Co-Founder

Sort

20 May 2021|Switzerland|Pharmaceuticals

Target: SWIXX BIOPHARMA

Bidder: MERIEUX EQUITY PARTNERS

9 Service Providers

6 Target | 3 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 34 M

Value

22 May 2024|Panama|Pharmaceuticals

Target: BIOPAS

Bidder: SWIXX BIOPHARMA

5 Service Providers

2 Target | 3 Bidder

10 Dealmakers

8 Target | 2 Bidder

n/a

Value

15 Dec 2025|Switzerland|Pharmaceuticals

Target: SWIXX BIOPHARMA

Bidder: SK CAPITAL PARTNERS

16 Service Providers

7 Target | 9 Bidder

41 Dealmakers

5 Target | 36 Bidder

n/a

Value